Antidepressant Activity of Curcuma heyneana

Author:

Marianne MarianneORCID,Hasibuan Poppy Anjelisa,Bin Emran TalhaORCID,Ramadhayani Sartika,Nasution Rosnani,Bastian Reza Akbar

Abstract

BACKGROUND: The resistance to depression therapy remains high, and therapy failure leads to suicide. Curcuma heyneana (C. heyneana) is a plant of Zingiberaceae. Conventionally, the rhizome has been used as an anxiolytic and sedative. However, the activity as antidepression has never been conducted. AIM: Therefore, this research was aimed to investigate the antidepressant activity of C. heyneana rhizome. METHODS: This research was conducted using male mice aged 2–3 months. Chronic mild stress for 14 days was used to induce depression, followed by administration of the extract at 50, 100, and 200 mg/kg for 10 days. Evaluation of antidepression was carried out using tail suspension test (TST), forced swim test (FST), open field test (OFT), and blood glucose and injury of gastric. Sertraline at the dose of 6.5 mg/kg was used as a positive control. RESULTS: The result revealed that stress induction for 14 days causes decreasing in locomotor activity and increased immobility. The extract administration at the doses of 100 and 200 mg/kg showed increased locomotor activity, which can be seen from the elevation of the central square and cross in the OFT (p < 0.05). The extract also decreased immobility in the tail suspension and FSTs (p < 0.05). Furthermore, the extract also prevents increases in blood glucose and gastric irritation. CONCLUSION: Extract of C. heyneana rhizome at the doses of 100 and 200 mg/kg has antidepressant activity by increasing locomotor activity, decreasing immobility time, and preventing elevation of blood glucose and gastric injury.

Publisher

Scientific Foundation SPIROSKI

Subject

General Medicine

Reference38 articles.

1. Delgado PL. Depression: The case for a monoamine deficiency. J Clin Psychiatry. 2000;61(6):7-11. PMid:10775018

2. Teter CJ, Kando JC. Major depressive disorder. In: Dipiro JT, Talbert RL, Yee GC, Matzke GR, Wells BG PL, editors. Pharmacotherapy, Pathophysiologic Approach. 8th ed. United States: McGraw-Hill; 2011. p. 1173-90.

3. Alexander RC, Preskorn S. Clinical pharmacology in the development of new antidepressants: The challenges. Curr Opin Pharmacol. 2014;14:6-10. PMid:24565005

4. Rush AJ, Fava M, Wisniewski SR, Lavori PW, Trivedi MH, Sackeim HA, et al. Sequenced treatment alternatives to relieve depression (STAR* D): Rationale and design. Control Clin Trials. 2004;25(1):119-42. https://doi.org/10.1016/s0197-2456(03)00112-0 PMid:15061154

5. Agoes A. Tanaman Obat Indonesia. Jakarta: Salemba Medika; 2010. p. 99-100.

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. Bioactive Compounds and Biological Activities of Curcuma Species;Reference Series in Phytochemistry;2024

2. Bioactive Compounds and Biological Activities of Curcuma Species;Reference Series in Phytochemistry;2023

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3